Capital World Investors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-34,200
| Closed | -$7.37M | – | 539 |
|
|
2024
Q1 | $7.37M | Hold |
34,200
| – | – | ﹤0.01% | 479 |
|
|
2023
Q4 | $8.85M | Buy |
+34,200
| New | +$8.4M | ﹤0.01% | 464 |
|
|
2021
Q3 | – | Sell |
-330,992
| Closed | -$115M | – | 614 |
|
|
2021
Q2 | $115M | Hold |
330,992
| – | – | 0.02% | 370 |
|
|
2021
Q1 | $92.6M | Buy |
+330,992
| New | +$89.3M | 0.02% | 375 |
|
|
2020
Q4 | – | Sell |
-317,974
| Closed | -$90.2M | – | 570 |
|
|
2020
Q3 | $90.2M | Buy |
317,974
+300,474
| +1,717% | +$83.8M | 0.02% | 343 |
|
|
2020
Q2 | $4.68M | Sell |
17,500
-700,908
| -98% | -$211M | ﹤0.01% | 496 |
|
|
2020
Q1 | $227M | Sell |
718,408
-1,109,838
| -61% | -$337M | 0.07% | 215 |
|
|
2019
Q4 | $542M | Sell |
1,828,246
-1,423,225
| -44% | -$395M | 0.12% | 162 |
|
|
2019
Q3 | $757M | Sell |
3,251,471
-823,456
| -20% | -$192M | 0.18% | 124 |
|
|
2019
Q2 | $953M | Sell |
4,074,927
-826,933
| -17% | -$191M | 0.22% | 118 |
|
|
2019
Q1 | $1.16B | Buy |
4,901,860
+886,293
| +22% | +$279M | 0.28% | 96 |
|
|
2018
Q4 | $1.21B | Buy |
4,015,567
+1,541,859
| +62% | +$492M | 0.33% | 79 |
|
|
2018
Q3 | $874M | Buy |
2,473,708
+2,063,598
| +503% | +$710M | 0.21% | 124 |
|
|
2018
Q2 | $119M | Buy |
410,110
+200,483
| +96% | +$56.4M | 0.03% | 292 |
|
|
2018
Q1 | $57.4M | Buy |
209,627
+110,227
| +111% | +$34.2M | 0.01% | 351 |
|
|
2017
Q4 | $31.7M | Buy |
+99,400
| New | +$31.9M | 0.01% | 391 |
|
|
2016
Q2 | – | Sell |
-600,000
| Closed | -$156M | – | 499 |
|
|
2016
Q1 | $156M | Sell |
600,000
-310,000
| -34% | -$81.9M | 0.04% | 244 |
|
|
2015
Q4 | $279M | Sell |
910,000
-291,651
| -24% | -$83.8M | 0.08% | 202 |
|
|
2015
Q3 | $351M | Sell |
1,201,651
-376,028
| -24% | -$124M | 0.1% | 181 |
|
|
2015
Q2 | $637M | Buy |
1,577,679
+53,979
| +4% | +$21.7M | 0.17% | 136 |
|
|
2015
Q1 | $643M | Sell |
1,523,700
-186,800
| -11% | -$73.6M | 0.17% | 138 |
|
|
2014
Q4 | $581M | Buy |
1,710,500
+930,000
| +119% | +$301M | 0.16% | 146 |
|
|
2014
Q3 | $258M | Buy |
780,500
+370,000
| +90% | +$122M | 0.07% | 212 |
|
|
2014
Q2 | $129M | Buy |
410,500
+358,000
| +682% | +$108M | 0.04% | 283 |
|
|
2014
Q1 | $16.1M | Hold |
52,500
| – | – | ﹤0.01% | 438 |
|
|
2013
Q4 | $14.7M | Hold |
52,500
| – | – | ﹤0.01% | 435 |
|
|
2013
Q3 | $12.6M | Hold |
52,500
| – | – | ﹤0.01% | 438 |
|
|
2013
Q2 | $11.3M | Buy |
+52,500
| New | +$11.2M | ﹤0.01% | 427 |
|
Other funds holding BIIB
Capital World Investors's BIIB Position: Q2 2024 in Review
Capital World Investors sold out of Biogen (BIIB) in Q2 2024, closing a stake of 34,200 shares — an estimated $7.37M sold.
Capital World Investors first reported a position in BIIB in Q2 2013 and held it in 28 quarters. The position peaked at $1.21B in Q4 2018. 943 funds tracked by Wall St. Rank hold BIIB as of Q2 2024.
- Capital World Investors reported no remaining Biogen position as of Q2 2024 after selling out during the quarter.
- Capital World Investors sold 34,200 Biogen shares in Q2 2024, an estimated $7.37M.
- Capital World Investors first reported a position in Biogen in Q2 2013 and held it in 28 quarters.
- Capital World Investors's Biogen position peaked at $1.21B in Q4 2018.
- 943 funds tracked by Wall St. Rank held Biogen as of Q2 2024.
Based on Capital World Investors's 13F filing for Q2 2024, filed 13 Aug 2024.